{{Drugbox
| verifiedrevid = 470609802
| IUPAC_name = <small>L</small>-arginyl-<small>L</small>-lysyl-<small>L</small>-α-aspartyl-<small>L</small>-valyl-<small>L</small>-tyrosine
| image = Thymopentin.png

<!--Clinical data-->
| tradename =  
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category =  
| legal_AU = <!-- Unscheduled / S2 / S3 / S4 / S5 / S6 / S7 / S8 / S9 -->
| legal_CA = <!--             / Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL         / P       / POM / CD / Class A, B, C -->
| legal_US = <!-- OTC                   / Rx-only  / Schedule I, II, III, IV, V -->
| legal_status =  
| routes_of_administration =

<!--Pharmacokinetic data-->
| bioavailability =  
| protein_bound =  
| metabolism =  
| elimination_half-life =  
| excretion =

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number =  
| ATC_prefix = L03
| ATC_suffix = AX09
| PubChem = 451417
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank =  
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 397640
| NIAID_ChemDB = 000127
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = O3Y80ZF13F
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D06117
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 156025

<!--Chemical data-->
| C=30 | H=49 | N=9 | O=9 
| molecular_weight = 679.76496 g/mol
| smiles = O=C(N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)N[C@H](C(=O)O)Cc1ccc(O)cc1)C(C)C)CC(=O)O)CCCCN)[C@@H](N)CCC/N=C(\N)N
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C30H49N9O9/c1-16(2)24(28(46)38-22(29(47)48)14-17-8-10-18(40)11-9-17)39-27(45)21(15-23(41)42)37-26(44)20(7-3-4-12-31)36-25(43)19(32)6-5-13-35-30(33)34/h8-11,16,19-22,24,40H,3-7,12-15,31-32H2,1-2H3,(H,36,43)(H,37,44)(H,38,46)(H,39,45)(H,41,42)(H,47,48)(H4,33,34,35)/t19-,20-,21-,22-,24-/m0/s1
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = PSWFFKRAVBDQEG-YGQNSOCVSA-N
| synonyms = <small>(3''S'')-3-{{bracket|[(2''S'')-6-amino-2-{{bracket|[(2''S'')-2-amino-5-(diaminomethylideneamino)pentanoyl]amino}}hexanoyl]amino}}-4-{{bracket|[(2''S'')-1-{{bracket|[(2''S'')-1-hydroxy-3-(4-hydroxyphenyl)-1-oxopropan-2-yl]amino}}-3-methyl-1-oxobutan-2-yl]amino}}-4-oxobutanoic acid</small>
}}

'''Thymopentin''' is an [[immunostimulant]]. As such, it has been used in several clinical studies in the early years of the [[AIDS]] pandemic (from 1983 to 1985). Thymopentin helped to improve immunological condition in several patients for a brief time under specific treatments.<ref name="pmid6193382">{{cite journal |vauthors=Mascart-Lemone F, Huygen K, Clumeck N,  Brenez D, Bolla K, Duchateau J |title=Stimulation of cellular function by thymopentin (TP-5) in three AIDS patients |journal=Lancet |volume=322 |issue=8352 |pages=735–736 |year=1983 |pmid=6193382 |doi=10.1016/S0140-6736(83)92271-7 |url=http://www.lancet.com/journals/lancet/article/PIIS0140-6736(83)92271-7/fulltext}}</ref><ref name="pmid6398315">{{cite journal |vauthors=Clumeck N, Van de Perre P, Mascart-Lemone F,  Cran S, Bolla K, Duchateau J |title=Preliminary results on clinical and immunological effects of thymopentin in AIDS |journal=Int J Clin Pharmacol Res |volume=4 |issue= |pages=459–463 |year=1984 |pmid=6398315 |url=http://europepmc.org/abstract/MED/6398315}}</ref><ref name="pmid3898293">{{cite journal |vauthors=Clumeck N, Cran S, Van de Perre P, Mascart-Lemone F, Duchateau J, Bolla K |title=Thymopentin treatment in AIDS and pre-AIDS patients |journal=Surv Immunol Res |volume=4 |issue=1 |pages=supp1 58–62 |year=1985 |pmid=3898293  |url=https://link.springer.com/article/10.1007%2FBF02919057 |doi=10.1007/BF02919057}}</ref>

It interacts with [[T cell]]s.<ref name="pmid18159232">{{cite journal |vauthors=Liu Z, Zheng X, Wang J, Wang E |editor1-last=Egli |editor1-first=Martin |title=Molecular analysis of thymopentin binding to HLA-DR molecules |journal=PLoS ONE |volume=2 |issue=12 |pages=e1348 |year=2007 |pmid=18159232 |pmc=2137936 |doi=10.1371/journal.pone.0001348 |url=http://www.plosone.org/article/info:doi/10.1371/journal.pone.0001348}} {{open access}}</ref>

It is a [[thymic]] [[polypeptide]].<ref name="pmid18692582">{{cite journal  |vauthors=Peng Y, Chen Z, Yu W, etal |title=Effects of thymic polypeptides on the thymopoiesis of mouse embryonic stem cells |journal=Cell Biology International |volume= 32|issue= 10|pages= 1265–71|date=July 2008 |pmid=18692582 |doi=10.1016/j.cellbi.2008.07.011 |url=http://linkinghub.elsevier.com/retrieve/pii/S1065-6995(08)00501-5}}</ref>

==References==
{{Reflist}}

{{Immunostimulants}}

[[Category:Peptides]]
[[Category:Immunostimulants]]


{{antineoplastic-drug-stub}}